HK1135731A1 - Vectors for multiple gene expression - Google Patents
Vectors for multiple gene expressionInfo
- Publication number
- HK1135731A1 HK1135731A1 HK10103937.8A HK10103937A HK1135731A1 HK 1135731 A1 HK1135731 A1 HK 1135731A1 HK 10103937 A HK10103937 A HK 10103937A HK 1135731 A1 HK1135731 A1 HK 1135731A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- vectors
- gene expression
- multiple gene
- expression
- gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/863—Poxviral vectors, e.g. entomopoxvirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07360019 | 2007-05-15 | ||
PCT/EP2008/051031 WO2008138648A1 (en) | 2007-05-15 | 2008-01-29 | Vectors for multiple gene expression |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1135731A1 true HK1135731A1 (en) | 2010-06-11 |
Family
ID=39522406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10103937.8A HK1135731A1 (en) | 2007-05-15 | 2010-04-21 | Vectors for multiple gene expression |
Country Status (17)
Country | Link |
---|---|
US (1) | US8337859B2 (ja) |
EP (1) | EP2162544B1 (ja) |
JP (1) | JP5474767B2 (ja) |
KR (1) | KR101514473B1 (ja) |
CN (1) | CN101688223B (ja) |
AR (1) | AR065075A1 (ja) |
AU (1) | AU2008250520B2 (ja) |
BR (1) | BRPI0810305A2 (ja) |
CA (1) | CA2686772C (ja) |
ES (1) | ES2416361T3 (ja) |
HK (1) | HK1135731A1 (ja) |
IL (1) | IL201963A (ja) |
MX (1) | MX2009012272A (ja) |
PE (1) | PE20090483A1 (ja) |
RU (1) | RU2462513C2 (ja) |
TW (1) | TW200844231A (ja) |
WO (1) | WO2008138648A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20090683A1 (es) | 2007-05-15 | 2009-06-27 | Transgene Sa | Peptidos de senalizacion |
US9206440B2 (en) * | 2009-01-23 | 2015-12-08 | Roger Williams Hospital | Viral vectors encoding multiple highly homologus non-viral polypeptides and the use of same |
WO2011015656A2 (en) * | 2009-08-07 | 2011-02-10 | Transgene Sa | Composition for treating hbv infection |
WO2011127924A2 (de) * | 2010-04-16 | 2011-10-20 | Charité - Universitätsmedizin Berlin | Mittel zur lokalen behandlung von zervixdysplasien |
GB201016471D0 (en) * | 2010-09-30 | 2010-11-17 | Isis Innovation | Viral vector immunogenic compositions |
US9216213B2 (en) * | 2011-04-20 | 2015-12-22 | Merial, Inc. | Adjuvanted rabies vaccine with improved viscosity profile |
ES2646590T3 (es) * | 2012-01-24 | 2017-12-14 | Sanford Health | Polinucleótidos para el tratamiento de tumores positivos para polipéptidos víricos oncogénicos |
US10363293B2 (en) | 2013-02-21 | 2019-07-30 | Turnstone Limited Partnership | Vaccine composition |
WO2016061182A1 (en) * | 2014-10-14 | 2016-04-21 | The Trustees Of The University Of Pennsylvania | Combination therapy for use in cancer therapy |
ES2634802B1 (es) * | 2016-03-28 | 2018-07-03 | Victor Manuel GALVEZ JEREZ | Molécula de ácido nucleico y método para modificar de forma bialélica un gen diana o locus presente en el material genético de una célula |
JP7053491B2 (ja) * | 2016-05-02 | 2022-04-12 | ヤンセン ファッシンズ アンド プリベンション ベーフェー | 治療用hpvワクチン組み合わせ |
US11466292B2 (en) | 2016-09-29 | 2022-10-11 | Glaxosmithkline Biologicals Sa | Compositions and methods of treatment |
EP3461497A1 (en) | 2017-09-27 | 2019-04-03 | GlaxoSmithKline Biologicals S.A. | Viral antigens |
JP7319368B2 (ja) * | 2018-11-21 | 2023-08-01 | メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ | アデノウイルスおよびアデノウイルスを使用するための方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9105383D0 (en) * | 1991-03-14 | 1991-05-01 | Immunology Ltd | An immunotherapeutic for cervical cancer |
PL337672A1 (en) | 1997-06-30 | 2000-08-28 | Nippon Kayaku Kk | Novel derivatives of naphtyridine or their salts |
FR2766091A1 (fr) | 1997-07-18 | 1999-01-22 | Transgene Sa | Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee |
FR2774699B1 (fr) | 1997-11-17 | 2003-10-03 | Rhone Poulenc Rorer Sa | Methode de reduction des evenements de recombinaison homologue |
WO2001014416A2 (en) * | 1999-08-25 | 2001-03-01 | Merck & Co., Inc. | Synthetic papillomavirus genes optimized for expression in human cells |
US7001995B1 (en) | 1999-08-25 | 2006-02-21 | Merck & Co., Inc. | Synthetic human papillomavirus genes |
EP1427443A4 (en) | 2001-08-23 | 2006-03-08 | Merck & Co Inc | VACCINE USING VIRUS VIRUS-ADJUSTED PAPILLOMA VIRUS PROTEINS |
CN101831411A (zh) * | 2002-05-16 | 2010-09-15 | 巴法里安诺迪克有限公司 | 表达插入痘病毒基因组中的同源基因的重组痘病毒 |
WO2008092854A2 (en) * | 2007-01-30 | 2008-08-07 | Transgene S.A. | Papillomavirus e2 polypeptide used for vaccination |
-
2008
- 2008-01-29 MX MX2009012272A patent/MX2009012272A/es active IP Right Grant
- 2008-01-29 CA CA2686772A patent/CA2686772C/en not_active Expired - Fee Related
- 2008-01-29 ES ES08708348T patent/ES2416361T3/es active Active
- 2008-01-29 TW TW097103228A patent/TW200844231A/zh unknown
- 2008-01-29 PE PE2008000210A patent/PE20090483A1/es not_active Application Discontinuation
- 2008-01-29 RU RU2009144898/10A patent/RU2462513C2/ru active
- 2008-01-29 CN CN200880016061XA patent/CN101688223B/zh not_active Expired - Fee Related
- 2008-01-29 KR KR1020097023308A patent/KR101514473B1/ko active IP Right Grant
- 2008-01-29 WO PCT/EP2008/051031 patent/WO2008138648A1/en active Application Filing
- 2008-01-29 AR ARP080100356A patent/AR065075A1/es not_active Application Discontinuation
- 2008-01-29 BR BRPI0810305A patent/BRPI0810305A2/pt not_active Application Discontinuation
- 2008-01-29 US US12/599,971 patent/US8337859B2/en active Active
- 2008-01-29 AU AU2008250520A patent/AU2008250520B2/en not_active Ceased
- 2008-01-29 JP JP2010507858A patent/JP5474767B2/ja not_active Expired - Fee Related
- 2008-01-29 EP EP08708348.1A patent/EP2162544B1/en not_active Not-in-force
-
2009
- 2009-11-05 IL IL201963A patent/IL201963A/en active IP Right Grant
-
2010
- 2010-04-21 HK HK10103937.8A patent/HK1135731A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR101514473B1 (ko) | 2015-04-22 |
JP2010526547A (ja) | 2010-08-05 |
AU2008250520A1 (en) | 2008-11-20 |
AU2008250520B2 (en) | 2013-10-31 |
CN101688223B (zh) | 2013-07-31 |
CA2686772A1 (en) | 2008-11-20 |
IL201963A0 (en) | 2011-08-01 |
TW200844231A (en) | 2008-11-16 |
ES2416361T3 (es) | 2013-07-31 |
EP2162544A1 (en) | 2010-03-17 |
AR065075A1 (es) | 2009-05-13 |
WO2008138648A1 (en) | 2008-11-20 |
PE20090483A1 (es) | 2009-05-20 |
CN101688223A (zh) | 2010-03-31 |
IL201963A (en) | 2013-09-30 |
JP5474767B2 (ja) | 2014-04-16 |
US20100303838A1 (en) | 2010-12-02 |
KR20100019432A (ko) | 2010-02-18 |
RU2009144898A (ru) | 2011-06-20 |
US8337859B2 (en) | 2012-12-25 |
MX2009012272A (es) | 2009-12-01 |
RU2462513C2 (ru) | 2012-09-27 |
BRPI0810305A2 (pt) | 2018-07-10 |
CA2686772C (en) | 2015-03-24 |
EP2162544B1 (en) | 2013-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1135731A1 (en) | Vectors for multiple gene expression | |
IL215804A0 (en) | Gene vector | |
IL205518A0 (en) | Distributed netork for performing complex algorithms | |
DK200800103A (en) | Integreret føringskant for vindturbineblad | |
EP2114280A4 (en) | IMPROVED MANIPULATOR | |
EP2342335A4 (en) | NEW GROUP OF GENES | |
EP2126120A4 (en) | Gene Expression Test Methods | |
EP2169055A4 (en) | NEW LYSOPHOSPHATIDATE ACYLTRANSFERASE GENE | |
ZA201006797B (en) | Expression-linked gene discovery | |
IL206170A0 (en) | Mammalian expression vector | |
GB0800702D0 (en) | Genes | |
EP2212435A4 (en) | FUSIONED GENE BZW. FUSIONED GENES | |
GB0820631D0 (en) | Vectors | |
IL191885A0 (en) | Multiple | |
HK1141831A1 (en) | Vector for gene therapy | |
GB0714573D0 (en) | Marker gene | |
EP2151495A4 (en) | HCV GENE | |
GB0713179D0 (en) | Vectors for cloning | |
GB0810154D0 (en) | Expression vector | |
GB0702694D0 (en) | Vectors | |
EP2161335A4 (en) | NEW GPIIIa GEN | |
GB0617387D0 (en) | Synthetic gene | |
AU2008905719A0 (en) | Genetic vectors | |
GB0811149D0 (en) | Gene | |
GB0823425D0 (en) | Vectors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220201 |